Arab Pharmaceuticals is a quiet pillar of Egypt's drug industry, majority-owned by the state and steadily growing its profits. It makes medicines that Egyptians rely on every day, and its latest results show a company gaining momentum. Full nameThe Arab Drug Company for Pharmaceuticals and Chemical Industries Tickers / exchangeADCI / Egyptian Exchange (EGX) HeadquartersCairo, Egypt SectorPharmaceuticals EmployeesNot published in available sources Market valueNot published in available sources Yearly sales (revenue)EGP 1,118.18 million (US$21.4 million) — FY2024/25 Net profitEGP 227.857 million (US$4.36 million) — FY2024/25 Net margin20.4% (our calculation) Return …
Company Intelligence — Institutional Access
This dossier is part of our Company Intelligence database.
Full profiles, exchange dossiers and the regional intelligence briefs are available to institutional subscribers. Professional from US$490/year, Corporate US$1,450, Institutional US$3,900.
See institutional access →Already a subscriber? Log in.
Part of LatAm Company Intelligence
This company profile belongs to The Rio Times' research on every listed company and exchange in Latin America and the Caribbean. Browse the full intelligence hub →
Not ready to buy? Try Company Intelligence free for 14 days →
Editorial responsibility: Matthias Camenzind, Editor-in-Chief · Editorial standards · Report an error
Read More from The Rio Times
The Rio Times · Power Map
See who really holds power in Latin America
Click to open the Power Map →